S. K. Reehana, et al. “LC and LC-MS MS Studies for the Characterization of Forced Degradation Products of Tucatinib, a Novel Tyrosine Kinase Inhibitor”. Challenges and Advances in Pharmaceutical Research Vol. 10, Nov. 2022, pp. 37-55, doi:10.9734/bpi/capr/v10/4705A.